tiprankstipranks
Trending News
More News >
Taoka Chemical Co., Ltd. (JP:4113)
:4113
Japanese Market
Advertisement

Taoka Chemical Co., Ltd. (4113) AI Stock Analysis

Compare
0 Followers

Top Page

JP:4113

Taoka Chemical Co., Ltd.

(4113)

Select Model
Select Model
Select Model
Neutral 69 (OpenAI - 4o)
Rating:69Neutral
Price Target:
¥1,380.00
▲(9.26% Upside)
Taoka Chemical Co., Ltd. has a strong financial foundation with solid revenue and profit growth, effective cost management, and robust cash flow. The stock appears undervalued with a low P/E ratio and an attractive dividend yield. However, technical indicators suggest bearish momentum, which could pose short-term risks.

Taoka Chemical Co., Ltd. (4113) vs. iShares MSCI Japan ETF (EWJ)

Taoka Chemical Co., Ltd. Business Overview & Revenue Model

Company DescriptionTaoka Chemical Company, Limited manufactures and sells various chemicals in Japan and internationally. It provides raw material for resists; one-component epoxy-based adhesives for bonding various materials; cyanoacrylate-based instant adhesives; and materials for electronic components, as well as amide and ester imide, nylon, polyester, and polyimide varnishes. The company also manufactures paper processing resin/water-soluble polymer products; raw materials for pharmaceuticals and diagnostics; and rubber additives, such as resin cross-linking agents, tackifiers, and kneading type vulcanizing adhesives. In addition, it offers plasticizer for food packaging films, flooring materials, footwear, hoses, ink rubber gloves, food cans, etc.; methyl ester used as a base material for industrial detergents, shell molds, and fine chemical intermediates, including fragrances and chemicals; dye-related products used for textiles, paper, leather, and plastics. Further, the company develops and produces bisphenol derivatives; TBIS, an epoxy derivative; TBIS, an acid dianhydride; episulfide derivatives; and indole derivatives for various compounds for medical and agrochemical applications. Taoka Chemical Company, Limited was formerly known as Taoka Dystuffs Manufacturing Co., Ltd. and changed its name to Taoka Chemical Company, Limited in 1972. The company was founded in 1919 and is headquartered in Osaka, Japan. Taoka Chemical Company, Limited is a subsidiary of Sumitomo Chemical Company, Limited.
How the Company Makes MoneyTaoka Chemical Co., Ltd. generates revenue primarily through the sale of its diverse array of chemical products. The company's key revenue streams include functional chemicals, which are used in various industrial applications, and electronic materials that serve the high-tech sector. Taoka's specialty chemicals are often customized to meet the specific needs of their clients, providing a competitive edge in the marketplace. Additionally, the company may engage in strategic partnerships and collaborations that enhance its product offerings and expand its market reach, contributing to its overall earnings.

Taoka Chemical Co., Ltd. Financial Statement Overview

Summary
Taoka Chemical Co., Ltd. shows a strong financial position with solid revenue and profit growth, effective cost management, and efficient use of equity. The company maintains a healthy balance sheet with low leverage and robust cash flow, supporting its ability to invest in future growth opportunities. However, attention should be paid to the slight decrease in the equity ratio.
Income Statement
75
Positive
The company's revenue growth has been positive, with a notable increase from the previous year. Gross profit margin is stable, indicating efficient production and cost management. Net profit margin has improved significantly, reflecting enhanced profitability. EBIT and EBITDA margins show strong operational performance, contributing to a solid income statement.
Balance Sheet
70
Positive
The balance sheet shows a strong equity position with a healthy debt-to-equity ratio, suggesting low leverage risks. The return on equity indicates efficient use of equity capital to generate profits. However, the equity ratio decreased slightly, indicating a minor shift in asset financing structure.
Cash Flow
80
Positive
The cash flow statement is robust, with strong operating cash flow and positive free cash flow growth. The operating cash flow to net income ratio suggests effective cash generation from operations. Free cash flow has been consistently positive, indicating good cash management and potential for reinvestment and growth.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue30.89B29.93B28.54B30.17B32.37B32.06B
Gross Profit5.77B5.49B4.58B4.00B6.32B7.22B
EBITDA3.74B3.46B2.60B1.95B4.25B5.16B
Net Income1.63B1.48B820.48M310.65M2.06B2.62B
Balance Sheet
Total Assets30.71B30.41B29.72B31.07B32.42B27.96B
Cash, Cash Equivalents and Short-Term Investments1.18B1.18B972.01M853.40M718.63M4.33B
Total Debt1.33B1.49B2.21B4.33B808.15M555.36M
Total Liabilities12.04B11.91B12.51B14.50B15.67B12.72B
Stockholders Equity18.68B18.50B17.21B16.57B16.75B15.24B
Cash Flow
Free Cash Flow0.002.97B2.49B-2.85B-3.41B3.16B
Operating Cash Flow0.004.37B3.63B1.48B-1.33B5.22B
Investing Cash Flow0.00-1.42B-1.14B-4.34B-2.08B-2.09B
Financing Cash Flow0.00-997.00M-2.39B3.00B-273.53M-680.45M

Taoka Chemical Co., Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price1263.00
Price Trends
50DMA
1369.67
Negative
100DMA
1308.58
Negative
200DMA
1177.35
Positive
Market Momentum
MACD
-23.39
Positive
RSI
39.81
Neutral
STOCH
40.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4113, the sentiment is Negative. The current price of 1263 is below the 20-day moving average (MA) of 1327.34, below the 50-day MA of 1369.67, and above the 200-day MA of 1177.35, indicating a neutral trend. The MACD of -23.39 indicates Positive momentum. The RSI at 39.81 is Neutral, neither overbought nor oversold. The STOCH value of 40.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4113.

Taoka Chemical Co., Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
80
Outperform
¥22.47B12.142.95%2.14%-5.12%
74
Outperform
¥19.72B9.363.87%11.19%122.83%
72
Outperform
¥16.98B12.124.13%11.01%105.63%
69
Neutral
¥18.10B11.133.17%7.57%35.66%
68
Neutral
¥25.14B9.993.71%-1.44%-1.26%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
¥16.36B11.732.61%4.46%25.80%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4113
Taoka Chemical Co., Ltd.
1,263.00
396.64
45.78%
JP:4064
Nippon Carbide Industries Company,Incorporated
2,095.00
487.91
30.36%
JP:4092
Nippon Chemical Industrial Co., Ltd.
2,856.00
242.32
9.27%
JP:4229
Gun Ei Chemical Industry Co., Ltd.
3,390.00
709.48
26.47%
JP:4409
Toho Chemical Industry Company, Limited
767.00
203.50
36.11%
JP:4973
Japan Pure Chemical Co., Ltd.
3,030.00
-297.16
-8.93%

Taoka Chemical Co., Ltd. Corporate Events

Taoka Chemical Reports Strong Financial Growth in Q1 2025
Jul 30, 2025

Taoka Chemical Co., Ltd. reported a significant increase in its financial performance for the three months ended June 30, 2025, with net sales rising by 12.6% and operating profit increasing by 45% compared to the same period last year. The company’s strong financial results indicate robust growth and improved profitability, which may enhance its competitive positioning in the chemical industry.

Taoka Chemical Reports Strong Quarterly Growth
Jul 30, 2025

Taoka Chemical Co., Ltd. reported a significant increase in its financial performance for the quarter ending June 2025, with net sales rising by 12.6% and operating profit increasing by 45%. This growth reflects the company’s strong market positioning and operational efficiency, which could positively impact stakeholders and enhance its competitive edge in the chemical industry.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 18, 2025